Envoy Medical Statistics
Share Statistics
Envoy Medical has 21.33M
shares outstanding. The number of shares has increased by 8.64%
in one year.
| Shares Outstanding | 21.33M |
| Shares Change (YoY) | 8.64% |
| Shares Change (QoQ) | 5.18% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 200 |
| FTD / Avg. Volume | 1.12% |
Short Selling Information
The latest short interest is 84.84K, so 0.4% of the outstanding
shares have been sold short.
| Short Interest | 84.84K |
| Short % of Shares Out | 0.4% |
| Short % of Float | 0.79% |
| Short Ratio (days to cover) | 7.54 |
Valuation Ratios
The PE ratio is -1.29 and the forward
PE ratio is -1.21.
Envoy Medical's PEG ratio is
0.03.
| PE Ratio | -1.29 |
| Forward PE | -1.21 |
| PS Ratio | 119.42 |
| Forward PS | 0.7 |
| PB Ratio | -1.43 |
| P/FCF Ratio | -1.42 |
| PEG Ratio | 0.03 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Envoy Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24,
with a Debt / Equity ratio of -1.04.
| Current Ratio | 1.24 |
| Quick Ratio | 1.02 |
| Debt / Equity | -1.04 |
| Debt / EBITDA | -0.99 |
| Debt / FCF | -1.04 |
| Interest Coverage | -23.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $5,357.14 |
| Profits Per Employee | $-495,119.05 |
| Employee Count | 42 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.43 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -39.13% in the
last 52 weeks. The beta is 2.32, so Envoy Medical's
price volatility has been higher than the market average.
| Beta | 2.32 |
| 52-Week Price Change | -39.13% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 2.02 |
| Relative Strength Index (RSI) | 56.21 |
| Average Volume (20 Days) | 17,888 |
Income Statement
In the last 12 months, Envoy Medical had revenue of 225K
and earned -20.8M
in profits. Earnings per share was -1.49.
| Revenue | 225K |
| Gross Profit | -517K |
| Operating Income | -19.26M |
| Net Income | -20.8M |
| EBITDA | -19.81M |
| EBIT | -19.98M |
| Earnings Per Share (EPS) | -1.49 |
Full Income StatementBalance Sheet
The company has 5.48M in cash and 19.66M in
debt, giving a net cash position of -14.18M.
| Cash & Cash Equivalents | 5.48M |
| Total Debt | 19.66M |
| Net Cash | -14.18M |
| Retained Earnings | -284.73M |
| Total Assets | 10.38M |
| Working Capital | 717K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -17.95M
and capital expenditures -980K, giving a free cash flow of -18.93M.
| Operating Cash Flow | -17.95M |
| Capital Expenditures | -980K |
| Free Cash Flow | -18.93M |
| FCF Per Share | -1.01 |
Full Cash Flow StatementMargins
Gross margin is -229.78%, with operating and profit margins of -8558.22% and -9242.22%.
| Gross Margin | -229.78% |
| Operating Margin | -8558.22% |
| Pretax Margin | -9242.22% |
| Profit Margin | -9242.22% |
| EBITDA Margin | -8802.67% |
| EBIT Margin | -8558.22% |
| FCF Margin | -8412.89% |
